Children’s Cancer Research Fund has a long-standing commitment to guarantee ongoing research support well into the future. Endowed chairs provide a constant stream of funding to keep research moving forward and help recruit and retain top faculty.
Children’s Cancer Research Fund Land Grant Chair
Bruce Blazar, M.D., Regents Professor, Division of Blood and Marrow Transplantation, Department of Pediatrics
Research Focus: Blazar’s research is focused on the role of the immune system in bone marrow transplantation and in models of disease
Children’s Cancer Research Fund Cancer Center Chair
Logan Spector, Ph.D. Associate Professor, Division of Epidemiology/Clinical Research, Department of Pediatrics
Research Focus: Spector’s research is focused on the causes of childhood leukemia, hepatoblastoma, and osteosarcoma
Children’s Cancer Research Fund/Suzanne Holmes Hodder Chair in Pediatric Cancer Research
Julie A. Ross, Ph.D.
Dr. Ross is the co-chief medical advisor of Children’s Cancer Research Fund, and a worldwide leader in childhood cancer epidemiology.
Research Focus: Ross’s research focuses on understanding the causes and consequences of childhood cancer and long-term survivorship health of survivors.
Hageboeck Family/Children’s Cancer Research Fund Chair
John Wagner, M.D.
Dr. Wagner is the co-chief medical advisor of Children’s Cancer Research Fund, director of the pediatric hematology/oncology/blood and marrow transplantation division and is internationally recognized as an expert in the field of stem cells and umbilical cord blood transplantation.
Research Focus: Wagner’s research focuses on understanding the biology of stem cells and their potential to treat disease and repair tissue.
Hedberg Family/Children’s Cancer Research Fund Chair for Brain Tumor Research
This chair for brain tumor research is currently open.
Lehman Family/Children’s Cancer Research Fund Chair
Brenda Weigel, M.D.
Dr. Weigel the Director of the Division of Pediatric Hematology/Oncology at the University of Minnesota. She is also vice-chair of the developmental therapeutics program for the Children’s Oncology Group.
Research Focus: Dr. Weigel focuses on advancing new therapies for patients, particularly therapies that harness the immune system’s role in fighting cancer.